The Biden administration said Thursday that it had reached an agreement with drugmakers to lower prices on the 10 costliest prescription drugs under Medicare. It's part of the federal government's ...

Prices for newly built homes fell in nearly a third of major U.S. cities over the past year, as builders ramped up concessions and focused on smaller floorplans in the face of weak demand. Nationally, ...

As more United States drug price changes have come to light this month, it remains clear that companies are tamping down their urge to jack them up, settling for more modest, across-the-board ...

CMS’ drug price negotiations are advancing, but new indications and exclusivity rules could complicate future pricing cycles. CMS gained the authority to negotiate list prices with drug manufacturers ...

Nearly half of U.S. home sellers have cut prices this fall, with a median markdown of 4%. Median list prices hold steady as days on market edge higher. AI Summary The fall housing market is sending a ...

After months of failed litigation from drugmakers, CMS released negotiated list prices for 10 of the country’s most expensive drugs. The Inflation Reduction Act, signed into law in August 2022, ...

The residential real estate market is slowly shaking off the cobwebs of a sluggish year of buying and selling, and quick-thinking homebuyers stand a good chance of snapping up a property at a lower ...

Drugmakers plan to raise U.S. prices on at least 250 branded medications including Pfizer PFE.N COVID-19 treatment Paxlovid, Bristol Myers Squibb's BMY.N cancer cell therapies and vaccines from France ...

Home prices have climbed at a historic pace in the United States in recent years. According to the Case-Shiller U.S. National Home Price Index, a typical single-family home is now about 50% more ...

Since the start of the COVID-19 pandemic, supply and demand dynamics have sent home prices surging by nearly 38% nationwide and about 35% in Georgia. But location matters in the U.S. housing market, ...

Popular diabetes drugs such as Ozempic and Trulicity are among 25 drugs Medicare has spent the most on but hasn't yet selected for price negotiation, according to a report released Thursday. The ...